|
Market Closed -
Swiss Exchange
19:31:16 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.68 CHF | +2.69% |
|
+6.80% | +79.50% |
| 09-14 | DocMorris Prices CHF97 Million Offering of Convertible Bonds Due 2031 | MT |
| 09-14 | Number of pharmacies declines, but a bit more slowly | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 539.2 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 86.47% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 741.5 | 771.3 | 758.1 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 73.76% | 4.02% | -1.72% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -6.62x | -15.2x | -243x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.67x | 1.79x | 1.84x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.3x | 2.6x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.43x | 0.38x | 0.35x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.59x | 0.55x | 0.49x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -53.7x | 34.8x | 14.5x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -11.8x | -32.6x | 169x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -9.39x | -22.8x | -63.3x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -10.7% | -4.38% | -1.58% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.614 | -0.7017 | -0.044 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,261 | 1,405 | 1,540 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -13.81 | 22.16 | 52.41 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -62.78 | -23.68 | 4.495 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -85.9 | -38.94 | -9.923 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 202.3 | 232.1 | 218.8 |
| Reference price 2 | 235.50 | 25.56 | 73.75 | 19.98 | 5.95 | 10.68 | 10.68 | 10.68 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 50,489 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.62x | 0.59x | -53.69x | -.--% | 655M | |
| 16.52x | 0.66x | 9.83x | -.--% | 14.75B | |
| 16.37x | 0.73x | 7.65x | 2.28% | 6.34B | |
| 20.11x | 0.77x | 12.94x | 1.05% | 6.31B | |
| 14.67x | 0.9x | 6.29x | 2.88% | 4.12B | |
| 14.19x | 1.22x | 7.46x | 5.7% | 3.14B | |
| 14.1x | 0.6x | 4.6x | 5.12% | 3.12B | |
| 14.17x | 0.85x | 6.37x | 4.58% | 2.93B | |
| 36.65x | - | - | - | 2.85B | |
| Average | 15.57x | 0.79x | 0.18x | 2.7% | 4.91B | |
| Weighted average by Cap. | 17.30x | 0.76x | 7.79x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
